Mode of action/efficacy of available methods

Warning

Copper intrauterine device (Cu-IUD)

  • Inhibition of fertilisation by its toxic effect on sperm and ova. Adversely affects the motility and viability of sperm and the viability and transport of ova
  • If fertilisation does occur, the local endometrial inflammatory reaction prevents implantation
  • Can be inserted up to:
    • 5 days following first UPSI since LMP, or
    • 5 days after the earliest likely ovulation date
  • This is the most effective method of EC. Failure rate is below 0.1%

Ulipristal acetate (UPA-EC) (30mg)

  • Selective progesterone receptor modulator
  • Acts by delaying ovulation for at least 5 days, until sperm from the UPSI for which EC was taken are no longer viable
  • It delays ovulation even after the start of the luteinising hormone (LH) surge, whereas LNG-EC is no longer effective after the start of the LH surge
  • Not effective after ovulation
  • After UPA-EC, the majority of women will go on to ovulate later in the cycle and are therefore at risk of pregnancy from subsequent UPSI
  • It is essential that women are made aware of this risk and advised regarding ongoing contraception
    • Efficacy is dependent on timing of UPSI in relation to ovulation
    • The overall pregnancy rate after administration of UPA-EC is about 1% to 2%
  • Efficacy may be reduced in women with BMI greater than 30kg/m2 or weight greater than 85kg. Double dose UPA–EC is not currently recommended

Levonorgestrel (LNG-EC) (1.5mg)

  • Inhibits ovulation, delaying or preventing follicular rupture and causing luteal dysfunction
  • Needs to be taken prior to the start of the luteal hormone (LH) surge, LNG inhibits ovulation for the next 5 days, until sperm from the UPSI for which it was taken are no longer viable
  • UPA-EC can delay ovulation even after the start of LH surge
  • After taking LNG-EC, women who ovulate later in the cycle are at risk of pregnancy from further UPSI
  • It is essential that women are made aware of this risk and advised regarding ongoing contraception
    • Efficacy is dependent on timing of UPSI in relation to ovulation
    • Efficacy of LNG-EC within 72 hours of a single episode of UPSI is thought to be 85%
  • Women weighing greater than 70kg or BMI greater than 26 kg/m2, offer double dose (3mg) LNG-EC, if copper coil and UPA-EC are not appropriate

Editorial Information

Last reviewed: 31/03/2025

Next review date: 01/01/2027

Author(s): West of Scotland Managed Clinical Network for Sexual Health Clinical Guidelines Group.

Version: 9.1

Approved By: West of Scotland Managed Clinical Network for Sexual Health

Reviewer name(s): George Laird.